R. Daoud et al., The multidrug resistance protein is photoaffinity labeled by a quinoline-based drug at multiple sites, BIOCHEM, 39(20), 2000, pp. 6094-6102
Tumor cells overcome cytotoxic drug pressure by the overexpression of eithe
r or both transmembrane proteins, the P-glycoprotein (P-gp) and the multidr
ug resistance protein (MRP). The MRP has been shown to mediate the transpor
t of cytotoxic natural products, in addition to glutathione-, glucuronidate
-, and sulfate-conjugated cell metabolites. However, the mechanism of MRP d
rug binding and transport is at present not clear. In this study, we have u
sed a photoreactive quinoline-based drug, N-(hydrocinchonidin-8'-yl)-4-azid
o-2-hydroxybenzamide (IACI), to show the photoaffinity labeling of the 190
kDa protein in membranes from the drug resistant SCLC H69/AR cells. The pho
toaffinity labeling of the 190 kDa protein by IACI was saturable and specif
ic. The identity of the IACI-photolabeled protein as the MRP was confirmed
by immunoprecipitation with the monoclonal antibody QCRL-1. Furthermore, a
molar excess of leukotriene C-4, doxorubicin, colchicine, and other quinoli
ne-based drugs, including MK571, inhibited the photoaffinity labeling of th
e MRP. Drug transport studies showed lower IACI accumulation in MRP-express
ing cells which was reversed by depleting ATP levels in H69/AR cells. Mild
digestion of the purified IACI-photolabeled MRP with trypsin showed two lar
ge polypeptides (similar to 111 and similar to 85 kDa). The 85 kDa polypept
ide which contains the QCRL-1 and MRPm6 monoclonal antibody epitopes corres
ponds to the C-terminal half of the MRP (amino acids similar to 900-1531) c
ontaining the third multiple spanning domain (MSD3) and the second nucleoti
de binding site. The 111 kDa polypeptide which contains the epitope sequenc
e of the MRPr1 monoclonal antibody encodes the remainder of the MRP sequenc
e (amino acids 1-900) containing the MSD1 and MSD2 plus the first nucleotid
e binding domain. Cleveland maps of purified IACI-labeled 85 and 111 kDa po
lypeptides revealed 6 kDa and similar to 6 plus 4 kDa photolabeled peptides
, respectively. In addition, resolution of the exhaustively digested IACI-p
hotolabeled MRP by HPLC showed two major and one minor radiolabeled peaks t
hat eluted late in the gradient (60 to 72% acetonitrile). Taken together, t
he results of this study show direct binding of IACI to the MRP at physiolo
gically relevant sites. Moreover, IACI photolabels three small peptides whi
ch localize to the N- and C-halves of the MRP. Finally, IACI provides a sen
sitive and specific probe for studying MRP-drug interactions.